Big pharma is hungry, and is paying biotechs breathtaking prices to fill its pipelines. This made for a heady atmosphere at BioEurope in Düsseldorf this week.
In my August 16 blog, I discussed the European challenge to Google Library project. I was sceptical about the chances of its success. Recent declarations of the French National Library director, Jean-Noel Jeanneney, the main promoter of the project, only reinforce my scepticism. According to Mr. Jeanneney, the project will be most probably called Europeana, to reflect its Greek-Latin lineage.
For the first time biotechnology has overtaken software as the US venture capitalists’ darling, according to the quarterly MoneyTree Report published by PricewaterhouseCoopers last week.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.